NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 22 filers reported holding NEUROBO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -90.0% | 3,066 | -72.8% | 0.00% | – |
| Q1 2022 | $10,000 | +150.0% | 11,253 | +985.1% | 0.00% | – |
| Q3 2021 | $4,000 | -60.0% | 1,037 | -64.0% | 0.00% | – |
| Q2 2021 | $10,000 | -23.1% | 2,881 | +1.4% | 0.00% | – |
| Q1 2021 | $13,000 | +160.0% | 2,841 | +201.0% | 0.00% | – |
| Q4 2020 | $5,000 | -54.5% | 944 | -50.7% | 0.00% | – |
| Q3 2020 | $11,000 | -21.4% | 1,913 | +8.2% | 0.00% | – |
| Q2 2020 | $14,000 | +100.0% | 1,768 | +126.1% | 0.00% | – |
| Q4 2019 | $7,000 | – | 782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mount Yale Investment Advisors, LLC | 57,425 | $214,000 | 0.02% |
| UBS Group AG | 1,037 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 371 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 323 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 24,642 | $92,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 728 | $3,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 60,792 | $226,000 | 0.00% |
| STATE STREET CORP | 15,878 | $59,000 | 0.00% |
| MORGAN STANLEY | 141 | $0 | 0.00% |